Biosimilars Strategic Accounts Executive

Biogen; Atlanta (GA); On-site; USD 138,400 - 211,100; Full time

Benefits offered by this job

LTI grants

Full benefits

Job summary

Biogen in the United States seeks a Strategic Accounts Executive to drive productivity within key external accounts and support the adoption of our biosimilars into targeted treatment pathways across US markets.

You will partner with regional directors and cross‑functional teams to optimize access, reimbursement, and patient outcomes while maintaining alignment with label policy and regulatory requirements.

Qualifications

• Requires 5–7 years in pharmaceutical/biotech with cross-functional roles.
• Strong reimbursement and managed care knowledge.
• Solid understanding of health-care policies and OIG compliance.

Responsibilities

• Develop and execute key account strategies with regional director for long‑term profitability.
• Ensure compliance with laws, policies, and licensor agreements at global/local levels.
• Identify opportunities and trends to increase patient access and improve care quality.
• Maintain regular interactions with accounts, HCPs, and administrators to address needs.
• Collaborate with local commercial teams and cross‑functional partners to improve engagement and trust.
• Foster biosimilar marketplace advocacy through partnerships with SAE and HQ teams.
• Prioritize accounts and plans to guide adoption and engagement frequency.
• Manage projects related to account adoption of approved products.
• Provide medical/patient support aligned with label policies.

Skills

Strategic account management

Reimbursement management

Bio/pharma experience

Regulatory compliance

Cross‑functional collaboration

Travel readiness

Education

Bachelor's degree

MBA preferred

Job description

Biogen in the United States seeks a Strategic Accounts Executive to drive productivity within key external accounts and support the adoption of our biosimilars into targeted treatment pathways across US markets.

You will partner with regional directors and cross‑functional teams to optimize access, reimbursement, and patient outcomes while maintaining alignment with label policy and regulatory requirements.